Author

A. Pollock

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Martinez· 1 shared A. Read· 1 shared B. Jester· 1 shared C. Amendola· 1 shared C. Brady· 1 shared C. Gamble· 1 shared C. Loper· 1 shared C. Pensak· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Martinez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Recurrent evolution of small body size and loss of the sword ornament in Northern Swordtail fish

G. A. Preising, T. Gunn, J. J. Baczenas, A. Pollock, D. L. Powell, T. O. Dodge, J. A. Machin Kairuz, M. L. Savage, Y. Lu, M. Fitschen-Brown, M. Cummings, S. Thakur, M. Tobler, O. Rios-Cardenas, M. Morris, M. Schumer

The paper uses whole-genome sequencing to resolve phylogenetic relationships in Xiphophorus fish, revealing recurrent loss of sexually selected traits like body size and sword ornaments.

bioRxiv · Dec 24, 2022Evolutionary Biology

An oral protein cocktail therapeutic for C. difficile infection

H. Zhao, M. Dodds, A. Pollock, M. Gewe, A. Martinez, K. Keeney, B. Jester, M. Hutton, H. Tabakh, M. Zhang, M. Heinnickel, T. Paddock, S. Ertel, K. Aggarwal, C. Amendola, , Guzma

This paper describes an oral protein cocktail, LMN-201, for C. difficile infection, showing it achieves high cure rates and validates spirulina as a delivery platform.

bioRxiv · Dec 21, 2021 · PreprintBioengineering